Lyell Immunopharma Inc (LYEL)

Is Lyell Immunopharma Inc (LYEL) A Buy Now?

According to our latest analysis, LYEL could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 5 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on LYEL, as trading bullish markets is always a lot easier

1. RSI (Relative Strength Index): The RSI(14) value of 79.73 indicates that LYEL is overbought. This suggests that LYEL price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
2. STOCH (Stochastic Oscillator): The STOCH value of 81.71 indicates that LYEL is overbought. This means that LYEL price is at or near the highest level over a specified lookback period.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that LYEL is overbought. This suggests that LYEL price is at or near the highest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 33.40 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
5. CCI (Commodity Channel Index): A CCI(14) value of 231.41 indicates that LYEL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term LYEL price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Lyell Immunopharma Inc financial reports and earnings history, Lyell Immunopharma Inc (LYEL) stock could reach $95.28 by 2030, $483.28 by 2040 and $1,111.15 by 2050. See the projected annual prices until 2050 of the Lyell Immunopharma Inc stock below:

• Lyell Immunopharma Inc (LYEL) is expected to reach an average price of $200.06 in 2035, with a high prediction of $262.55 and a low estimate of $199.58. This indicates an +1,197% change from the last recorded price of $15.43.
• Lyell Immunopharma Inc (LYEL) stock is projected to chart a bullish course in 2040, with an average price target of $374.55, representing an +2,327% change from its current level. The forecast ranges from a conservative $376.15 to a sky-high $483.28.
• Our analysts predict Lyell Immunopharma Inc (LYEL) to change +4,091% by 2045, soaring from $639.90 to an average price of $646.65, potentially reaching $763.04. While $639.90 is the low estimate, the potential upside is significant.
• Lyell Immunopharma Inc (LYEL) stock is expected to climb by 2050, reaching an average of $936.74, a +5,971% change from its current level. However, a wide range of estimates exists, with high and low targets of $1,111.15 and $941.84, respectively, highlighting the market's uncertainty.

Lyell Immunopharma Inc Stock (LYEL) Year by Year Forecast